COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
Alejandro MoralesJaime García de TenaBegoña Frutos-PérezBeatriz Jaenes-BarriosAna Isabel Farfán-SedanoMiguel Ángel Canales-AlbendeaDavid Bernal-BelloPublished in: Cancer (2021)